ambrisentan 10 MG Oral Tablet
- RxCUI
- 722116
- RxNorm name
- ambrisentan 10 MG Oral Tablet
- Display name
- ambrisentan 10 MG Oral Tablet
- Full name
- ambrisentan 10 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ambrisentan | AMBRISENTAN | Zydus Pharmaceuticals USA Inc. | 37af3191-0ed3-4783-8747-065f1462f2d2 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Letairis | AMBRISENTAN | Gilead Sciences, Inc. | 725d4e73-6c83-477a-adc6-0ae4a133a844 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Golden State Medical Supply, Inc. | 4396bab5-2851-62ef-e063-6294a90af76e | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Quallent Pharmaceuticals Health LLC | 6fc6032f-94dc-4067-8b24-01990ec99db0 | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Mylan Pharmaceuticals Inc. | 8080b009-361b-4505-b09a-0d91a0e4a2c0 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Apotex Corp. | 291a782a-77e1-8a8e-e1c8-2626f305c2b7 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 722116 |
| ambrisentan | AMBRISENTAN | A-S Medication Solutions | a7dcdea4-d3da-4dc1-9193-6ebdb5b4e690 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Actavis Pharma, Inc. | 32549c43-f8ff-422c-b42d-ca0877e661cf | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 722116 |
| ambrisentan | AMBRISENTAN | Sun Pharmaceutical Industries, Inc. | a4978a54-1799-43d6-85dd-05fa9de0a5d7 | 2025-04-30 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Cipla USA Inc. | 0e418384-cae1-47ae-ac5e-afc845d694f6 | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | 722116 |
| ambrisentan | AMBRISENTAN | Aurobindo Pharma Limited | 82e51c75-fb78-4ad3-8bce-5e0581d60014 | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | 722116 |
| Ambrisentan | AMBRISENTAN | Zydus Lifesciences Limited | 0e3e3320-27ac-404f-9f01-3d82696e768a | 2024-11-25 | 722116 | |
| AMBRISENTAN | AMBRISENTAN | Sigmapharm Laboratories, LLC | e20ab2fe-bc9f-48a3-b15a-e4bc9532c2ac | 2023-01-10 | Boxed warning, Warnings, Adverse reactions | 722116 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 725d4e73-6c83-477a-adc6-0ae4a133a844 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 27 | These highlights do not include all the information needed to use LETAIRIS ® safely and effectively. See full prescribing information for LETAIRIS. Letairis (ambrisentan) tablets, for oral use Initial U.S. Approval: 2007 | 20250822 |
| 32549c43-f8ff-422c-b42d-ca0877e661cf | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 19 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS . AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20250530 |
| 37af3191-0ed3-4783-8747-065f1462f2d2 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 10 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20250415 |
| 0e3e3320-27ac-404f-9f01-3d82696e768a | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 10 | AMBRISENTAN Tablets | 20241125 |
| 291a782a-77e1-8a8e-e1c8-2626f305c2b7 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS . AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20251118 |
| a4978a54-1799-43d6-85dd-05fa9de0a5d7 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20250430 |
| 0e418384-cae1-47ae-ac5e-afc845d694f6 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20250422 |
| 8080b009-361b-4505-b09a-0d91a0e4a2c0 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20251205 |
| e20ab2fe-bc9f-48a3-b15a-e4bc9532c2ac | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN Tablets, for oral use Initial U.S. Approval: 2007 | 20230110 |
| 6fc6032f-94dc-4067-8b24-01990ec99db0 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20260105 |
| 4396bab5-2851-62ef-e063-6294a90af76e | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 3 | AMBRISENTAN TABLETS. These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20260127 |
| 82e51c75-fb78-4ad3-8bce-5e0581d60014 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20250421 |
| a7dcdea4-d3da-4dc1-9193-6ebdb5b4e690 | ambrisentan 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007 | 20251008 |